Global breast cancer therapeutics market size to exhibit 10.16% CAGR through 2027

Description – The research report on ‘global breast cancer therapeutics market’ offers significant information regarding this business landscape. It scrutinizes and provides data on the numerous growth catalysts, challenges & restraints and other expansion trends arresting the growth rate of this market over 2020-2027.

As per authentic predictions, global breast cancer therapeutics market had generated revenues worth USD 19.57 billion in the year 2019 and is expected to witness a y-o-y growth rate of 10.16% between 2020 and 2027. Increased pervasiveness of breast cancer, technological developments, and rising adoption of therapeutic drugs are projected to amplify product demand in the approaching years.

The study also elaborates on the different market segmentations which are predominately based on product type, distribution channel, and regional scope. Apart from this, the research document provides a detailed SWOT analysis of the several industry participants, further improving decision making during investment assessment.

Notably, there has been an upsurge in number of cases associated with early menarche, late menopause, and late birth. Additionally, high exposure to certain endocrine and carcinogens disruptors has increased the risk of acquiring breast cancer, which in turn is propelling the product demand.

Request Sample copy of this Report @

According to the World Health Organization (WHO), breast cancer affects over 2.1 million people annually and is a leading cause of malignancy-related deaths. In fact, mortality numbers associated with the disease had reached 627,000 in 2018 alone. Thus, increasing awareness regarding breast cancers and rising adoption of western lifestyle are stimulating global breast cancer therapeutics industry outlook.

Mounting consumption of alcohol, HRT (hormone replacement therapy), and oral birth control pills have resulted in increased levels of estrogen among the women population. Hence, growing popularity of therapeutic drugs owing to their ability to block estrogen from binding to tumor cells as well as reduce reoccurrence and minimize the overall risk of acquiring breast cancer is also adding traction to the market size.

Technological advancements and development of wide array of diagnostic and screen programs are favoring global breast cancer therapeutics market outlook. On the contrary, high costs associated with the product as well as the overall disease treatment may act as a restraining factor to the growth of the overall market.

A summary of the market segmentations

Global breast cancer therapeutics market is divided on the basis of product type and distribution channel. The product landscape comprises of targeted drug therapy, chemotherapy drugs, and hormone drugs segments.

Citing the distribution channel, the overall industry is bifurcated into retail pharmacies, e-commerce, clinics, ambulatory surgical centers, and hospitals.

To access a sample pages of this report titled “Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:

A gist of the regional scope

Worldwide breast cancer therapeutics market is classified into North America, Latin America, Europe, Asia-Pacific, and rest of the world.

According to credible estimations, North America captured the largest market share in the year 2018 and is predicted to display similar expansion trends in the ensuing years. High occurrence of breast cancer and escalating R&D investments by public and private entities are favoring the regional market outlook.

Expanding access to cancer care, rising adoption of tumor therapy, early-onset breastfeeding, and growing elderly population have augmented the demand for breast cancer therapeutics, thereby facilitating the business scenario in North America.

Global Breast Cancer Therapeutics Market by Product Type (Revenue, USD Billion, 2017-2027)

  • Targeted Drug Therapy
  • Chemotherapy Drugs
  • Hormone Drugs

Global Breast Cancer Therapeutics Market by Distribution Channel (Revenue, USD Billion, 2017-2027)

  • Retail Pharmacies
  • E-commerce
  • Clinics
  • Ambulatory Surgical Centers
  • Hospitals

Global Breast Cancer Therapeutics Market by Geographical Reach (Revenue, USD Billion, 2017-2027)

North America

  • U.S.
  • Canada

Latin America

  • Brazil
  • Mexico


  • Germany
  • Spain
  • UK
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Rest of the World

Global Breast Cancer Therapeutics Market Competitive Landscape (Revenue, USD Billion, 2017-2027)

  • Sanofi Genzyme
  • Pfizer Inc.
  • Novartis AG
  • Halozyme Therapeutics
  • GlaxoSmithKline plc
  • Genentech Inc.
  • Eli Lilly and Company
  • Eisai Co. Ltd
  • Bristol-Myers Squibb
  • AstraZeneca plc

Related Report:

Cancer Diagnostics Market, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

The global cancer diagnostics market share has been depicting a substantial expansion since the last decade or so on account of the increasing cancer prevalence worldwide. Unhealthy diet patterns, sedentary lifestyles including smoking and extensive alcohol consumption, and rising obesity are majorly responsible for the upsurge in the number of cancer cases. According to the American Cancer Society, here will be an anticipated 1.8 million new cancer cases that would be diagnosed in 2020 and 606,520 deaths from cancer, in the United States alone. Latin America is anticipated to emerge as a lucrative growth ground for cancer diagnostics market, driven by the robust prevalence of cancer in the region. Latin America market is anticipated to cross USD 7.3 billion by 2026.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150


Back to news